Related Experiment Video
Updated: Jul 9, 2026

Development and Standardization of an Ex Vivo Micromethod for Intracellular Quantification of Vincristine in Primary ALL Cells by LC-MS/MS
Published on: January 23, 2026
[A case undergoing repeated anaphylactic shock after systemic administration of vinorelbine]
Yoshimitsu Takahashi1, Takayoshi Kiba, Kayoko Yamaguchi
1Dept. of Pharmacy, Kanazawa Medical University Hospital.
Abstract:
We here describe a 49-year-old man who suffered repeated anaphylactic shock after systemic chemotherapy with vinorelbine for stage IV left lung adenocarcinoma (S1+2). He was treated using a combination of cisplatin and weekly irinotecan (CPT-11) as the first line; however, the regimen was changed to a combination of vinorelbine (VNR) and gemcitabine (GEM) because of his progressive disease. He was admitted to our hospital for examination of the unknown cause of hypotension and loss of consciousness. The second shock occurred after eating pistachios, and the third one at cancerous pain. After pain control, the shock no longer occurred. Anaphylactic shock may show two peaks and late symptoms. In patients with a history of anaphylactic shock, we should pay attention to foods, drugs, and various stresses which might cause anaphylaxis.
Related Concept Videos
Drug Toxicity: Allergic Reactions
Drug toxicity: Idiosyncratic Reactions
Allergic Reactions: Anaphylaxis
Allergic Drug Reactions
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Allergic Reactions